Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Glenmark released Picture Post Cards on World Vitiligo Day
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Subscribe To Our Newsletter & Stay Updated